Barclays Has Lowered Expectations for Acadia Healthcare (NASDAQ:ACHC) Stock Price

Acadia Healthcare (NASDAQ:ACHC) had its target price lowered by equities researchers at Barclays from $35.00 to $28.00 in a research note issued to investors on Wednesday,Benzinga reports. The brokerage currently has an “equal weight” rating on the stock. Barclays‘s price objective suggests a potential upside of 9.20% from the stock’s previous close.

ACHC has been the subject of a number of other reports. Mizuho lowered their price target on shares of Acadia Healthcare from $37.00 to $32.00 and set a “neutral” rating for the company in a report on Wednesday. KeyCorp lowered their price target on shares of Acadia Healthcare from $65.00 to $55.00 and set an “overweight” rating for the company in a report on Wednesday. Guggenheim initiated coverage on shares of Acadia Healthcare in a report on Wednesday, April 9th. They set a “buy” rating and a $36.00 price target for the company. Royal Bank of Canada lowered their price target on shares of Acadia Healthcare from $64.00 to $43.00 and set an “outperform” rating for the company in a report on Monday, March 3rd. Finally, Bank of America lowered their price target on shares of Acadia Healthcare from $50.00 to $44.50 and set a “buy” rating for the company in a report on Friday, February 28th. One equities research analyst has rated the stock with a sell rating, three have given a hold rating and six have issued a buy rating to the stock. According to data from MarketBeat.com, the company presently has an average rating of “Moderate Buy” and an average target price of $47.94.

Acadia Healthcare Stock Performance

Shares of ACHC opened at $25.64 on Wednesday. The company has a current ratio of 1.07, a quick ratio of 1.07 and a debt-to-equity ratio of 0.60. The stock has a market cap of $2.36 billion, a P/E ratio of 8.41, a PEG ratio of 1.46 and a beta of 1.01. The company has a 50-day moving average of $26.25 and a two-hundred day moving average of $35.83. Acadia Healthcare has a 12-month low of $20.36 and a 12-month high of $82.41.

Acadia Healthcare (NASDAQ:ACHC) last announced its earnings results on Monday, May 12th. The company reported $0.40 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.35 by $0.05. The company had revenue of $770.51 million during the quarter, compared to analysts’ expectations of $769.90 million. Acadia Healthcare had a net margin of 8.99% and a return on equity of 11.12%. The firm’s quarterly revenue was up .3% compared to the same quarter last year. During the same quarter in the previous year, the business posted $0.84 earnings per share. As a group, research analysts predict that Acadia Healthcare will post 3.38 EPS for the current fiscal year.

Institutional Investors Weigh In On Acadia Healthcare

A number of institutional investors have recently bought and sold shares of ACHC. Lindbrook Capital LLC grew its holdings in Acadia Healthcare by 1,342.0% in the fourth quarter. Lindbrook Capital LLC now owns 721 shares of the company’s stock valued at $29,000 after purchasing an additional 671 shares during the period. Blue Trust Inc. grew its holdings in Acadia Healthcare by 69.4% in the fourth quarter. Blue Trust Inc. now owns 842 shares of the company’s stock valued at $33,000 after purchasing an additional 345 shares during the period. UMB Bank n.a. grew its holdings in Acadia Healthcare by 149.5% in the first quarter. UMB Bank n.a. now owns 1,260 shares of the company’s stock valued at $38,000 after purchasing an additional 755 shares during the period. Caitong International Asset Management Co. Ltd grew its stake in Acadia Healthcare by 11,218.2% during the first quarter. Caitong International Asset Management Co. Ltd now owns 1,245 shares of the company’s stock worth $38,000 after buying an additional 1,234 shares during the period. Finally, Nisa Investment Advisors LLC grew its stake in Acadia Healthcare by 40.7% during the fourth quarter. Nisa Investment Advisors LLC now owns 1,040 shares of the company’s stock worth $41,000 after buying an additional 301 shares during the period.

About Acadia Healthcare

Acadia Healthcare Company, Inc provides behavioral healthcare services in the United States and Puerto Rico. The company develops and operates acute inpatient psychiatric facilities, specialty treatment facilities comprising residential recovery facilities and eating disorder facilities, comprehensive treatment centers, and residential treatment centers, as well as facilities offering outpatient behavioral healthcare services for the behavioral healthcare and recovery needs of communities.